Kenneth G. Mertz II
@Emerald Mutual Fund Advisers Trust
Latest period2024 - Q3ReportedManaged Assets$1.925BTotal holdings225
Assets growth rate0.84%Assets growth rate (2-Q avg)0.12%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Emerald Mutual Fund Advisers Trust's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 225 positions.
Assets under management
The assets under management (AUM) of Emerald Mutual Fund Advisers Trust over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.925B in assets, with a quarterly growth rate of 0.84% and a 2-quarter average growth rate of 0.12%. The portfolio is managed by Kenneth G. Mertz II, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
AVAVAerovironment Inc
| 1.71% | $32.87M 163,939 shares@ $200.51 avg price | Increased 3.13% |
PIImpinj Inc
| 1.62% | $31.01M 143,219 shares@ $216.53 avg price | Increased 4.16% |
BPMCBlueprint Medicines Corp
| 1.39% | $26.69M 288,540 shares@ $92.5 avg price | Increased 3.67% |
AXAxos Financial Inc
| 1.39% | $26.564M 422,460 shares@ $62.89 avg price | Increased 10.52% |
COLLCollegium Pharmaceutical Inc
| 1.33% | $25.591M 662,291 shares@ $38.64 avg price | Increased 24.86% |
LPXLouisiana-pacific Corporation
| 1.29% | $24.785M 230,642 shares@ $107.46 avg price | Increased 0.73% |
ITCIIntra Cellular Therapies
| 1.28% | $24.488M 334,673 shares@ $73.17 avg price | Increased 6.57% |
RAREUltragenyx Pharmaceutical Inc
| 1.24% | $23.848M 429,302 shares@ $55.55 avg price | Increased 9.93% |
PDFSPdf Solutions Inc
| 1.2% | $23.068M 728,144 shares@ $31.69 avg price | Increased 1.71% |
FORMFormfactor Inc
| 1.15% | $21.996M 478,170 shares@ $46.0 avg price | Increased 2.87% |